Crossmark

RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

Crossref DOI link: https://doi.org/10.15252/emmm.201910979

Published Online: 2020-05-18

Published Print: 2020-06-08

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Smith, Henry G

Jamal, Kunzah

Dayal, Jasbani HS

Tenev, Tencho

Kyula‐Currie, Joan

Guppy, Naomi

Gazinska, Patrycja

Roulstone, Victoria

Liccardi, Gianmaria

Davies, Emma

Roxanis, Ioannis

Melcher, Alan A

Hayes, Andrew J

Inman, Gareth J

Harrington, Kevin J

Meier, Pascal https://orcid.org/0000-0003-2760-6523
Funding

Funding for this research was provided by:

Breast Cancer Now (CTR‐QR14‐007)

Cancer Research UK (CRM089X)

Royal College of Surgeons of England (160729)

Sarcoma UK (SUK203.2016)

Sarcoma UK (SUK203.2017)

Rosetrees Trust (A1292)
License Information

Version of Record valid from 2020-05-18
More Information

Publication History

Received: 2019-06-11

Accepted: 2020-04-20

Published: 2020-05-18